We serve 1-Methoxy-2-(trifluoromethoxy)benzene CAS:261952-22-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Contact us for information like 1-Methoxy-2-(trifluoromethoxy)benzene chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-(Trifluoromethoxy)anisole physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,trifluoro(2-methoxyphenoxy)methane Use and application,trifluoro(2-methoxyphenoxy)methane technical grade,usp/ep/jp grade.
Related News: DPH and BPHC continue to work closely with the CDC to maintain vigilance during this virus outbreak.7-Amino-3-methoxy-3-cephem-4-carboxylic acid manufacturer By recapitulating the tumor microenvironment and using a live-cell, function-first approach, Resonant’s platform generates therapeutic candidates that would not be discovered by other methods with unprecedented speed.Trimethoxysilane supplier Beijing will strengthen its monitoring of overseas drug market and collect global prices for imported medicines, Friday’s guideline said.2,7-dibromotriphenylene vendor Rigosertib is a small molecule that inhibits cellular signaling in cancer cells by acting as a RAS mimetic. Current clinical development of rigosertib is centered upon the therapeutic management of MDS, a heterogeneous group of bone marrow disorders characterized by ineffective hematopoiesis that often develop into acute myeloid leukaemia (AML).Retrogenix and Resonant Therapeutics, Inc. recently announced they have entered into a non-exclusive strategic partnership to identify the targets of Resonant antibodies directed against the tumor microenvironment.
